A drug for treating diabetic nephropathy ⅳ stage of kidney deficiency and collateral stasis type

Abstract

A drug for treating kidney deficiency and collateral stasis type diabetic nephropathy stage IV, which consists of: 25-35g raw astragalus, 25-35g raw oyster, 25-35g Smilax, 25-35g Gorgon, 13-18g Hedyotis, ghost arrow Feather 8‑15g, Danshen 8‑13g, habitat 8‑12g, yam 7‑12g, dogwood 8‑12g, mulberry octopus 5‑12g. The present invention removes Scrophulariaceae, Atractylodes atractylodes, Radix Puerariae, Safflower, Alisma, and Rosa laevigata on the basis of Ziyue Yishen formula, and adds raw oyster, Hedyotis, ghost arrow feather, salvia miltiorrhiza, and mulberry octopus to strengthen blood circulation. Dispersing stagnation, removing blood stasis and dredging collaterals, clearing heat and detoxifying, so as to improve kidney function and reduce urine protein.

Description

technical field [0001] The invention relates to a medicine for treating the fourth stage of diabetic nephropathy of kidney deficiency and collateral stasis type, in particular a medicine prepared by adding and subtracting prescriptions on the basis of empirical prescription Zibi Yishen prescription. Background technique [0002] Diabetic nephropathy (DN) is a common and refractory microvascular complication of diabetes, and it is one of the main causes of death and disability in patients. Early detection of kidney damage, seeking active and effective treatment, and maximizing the control of DN (stage IV) disease are of great significance for delaying the progression of the disease and improving the quality of life of patients. Modern studies have shown that the occurrence and development of DN are closely related to protein non-enzymatic glycosylation, high blood viscosity, and hemodynamic abnormalities caused by high blood sugar. At present, the "Guidelines for the Prevent...

AI Technical Summary

Problems solved by technology

A large number of clinical studies have confirmed that traditional Chinese medicine has relatively obvious advantages in reducing the leakage of DN protein and improving renal function, especially according to the etiology and pathogenesis of DN, combined with clinical experience, an empirical prescription for the treatment of diabetic nephropathy (stage IV) with kidney deficiency and collateral stasis has been summarized. Zifen Yishen formula has achieved certain curative effect on improving patients’ symptoms such as backache, edema, dizziness and fatigue, but its curative effect still needs to be improved on improving patients’ renal function and reducing urinary protein

Images